Renal clearance of endogenous hippurate correlates with expression levels of renal organic anion transporters in uremic rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 314, Issue 2, 2005, Pages 932-938

  Deguchi, Tsuneo ^a   Takemoto, Mizue ^a   Uehara, Nao ^a   Lindup, W Edward ^b   Suenaga, Ayaka ^a   Otagiri, Masaki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOHIPPURIC ACID; CREATININE; HIPPURIC ACID; ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTER 3; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BILE DUCT; CHRONIC KIDNEY FAILURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; KIDNEY CLEARANCE; KIDNEY TUBULE; KIDNEY TUBULE EXCRETION; MALE; NEPHRECTOMY; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UREMIA; WESTERN BLOTTING;

ALGORITHMS; ANESTHESIA; ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CREATINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPURATES; KIDNEY; MALE; NEPHRECTOMY; ORGANIC ANION TRANSPORTERS; RATS; RATS, WISTAR; TISSUE DISTRIBUTION; UREMIA;

EID: 22944463031     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.105.085613     Document Type: Article

References (40)

1. Aoyama I, Enomoto A, and Niwa T (2003) Effects of oral adsorbent on gene expression profile in uremic rat kidney: cDNA array analysis. Am J Kidney Dis 41:S8-S14.
2. Boumendil-Podevin EF, Podevin RA, and Richet G (1975) Uricosuric agents in uremic sera. Identification of indoxyl sulfate and hippuric acid. J Clin Investig 55:1142-1152.
3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
4. Cha SH, Sekine T, Fukushima JI, Kanai Y, Kobayashi Y, Goya T, and Endou H (2001) Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol Pharmacol 59:1277-1286.
5. Costigan MG, Callaghan CA, and Lindup WE (1996) Hypothesis: is accumulation of a furan dicarboxylic acid (3-carboxy-4-methyl-5-propyl-2- furanpropanoic acid) related to the neurological abnormalities in patients with renal failure? Nephron 73:169-173.
6. Deguchi T, Kusuhara H, Takadate A, Endou H, Otagiri M, and Sugiyama Y (2004) Characterization of uremic toxin transport by organic anion transporters in the kidney. Kidney Int 65:162-174.
7. Deguchi T, Nakamura M, Tsutsumi Y, Suenaga A, and Otagiri M (2003) Pharmacokinetics and tissue distribution of uraemic indoxyl sulphate in rats. Biopharm Drug Dispos 24:345-355.
8. Dzurik R, Spustova V, Krivosikova Z, and Gazdikova K (2001) Hippurate participates in the correction of metabolic acidosis. Kidney Int Suppl 78:S278-S281.
9. Enomoto A, Takeda M, Shimoda M, Narikawa S, Kobayashi Y, Yamamoto T, Sekine T, Cha SH, Niwa T, and Endou H (2002) Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors. J Pharmacol Exp Ther 301:797-802.
10. Enomoto A, Takeda M, Taki K, Takayama F, Noshiro R, Niwa T, and Endou H (2003) Interactions of human organic anion as well as cation transporters with indoxyl sulfate. Eur J Pharmacol 466:13-20.
11. Eraly SA, Hamilton BA, and Nigam SK (2003) Organic anion and cation transporters occur in pairs of similar and similarly expressed genes. Biochem Biophys Res Commun 300:333-342.
12. Hasegawa M, Kusuhara H, Endou H, and Sugiyama Y (2003) Contribution of organic anion transporters to the renal uptake of anionic compounds and nucleoside derivatives in rat. J Pharmacol Exp Ther 305:1087-1097.
13. Hosoyamada M, Sekine T, Kanai Y, and Endou H (1999) Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am J Physiol 276:F122-F128.
14. Ilic S, Rajic M, Vlajkovic M, Bogicevic M, and Stefanovic V (2000) The predictive value of 131I-hippurate clearance in the prognosis of acute renal failure. Ren Fail 22:581-589.
15. Ji L, Masuda S, Saito H, and Inui K (2002) Down-regulation of rat organic cation transporter rOCT2 by 5/6 nephrectomy. Kidney Int 62:514-524.
16. Kojima R, Sekine T, Kawachi M, Cha SH, Suzuki Y, and Endou H (2002) Immunolocalization of multispecific organic anion transporters, OAT1, OAT2 and OAT3, in rat kidney. J Am Soc Nephrol 13:848-857.
17. Kusuhara H and Sugiyama Y (2002) Role of transporters in the tissue-selective distribution and elimination of drugs: transporters in the liver, small intestine, brain and kidney. J Control Release 78:43-54.
18. Laouari D, Yang R, Veau C, Blanke I, and Friedlander G (2001) Two apical multidrug transporters, P-gp and MRP2, are differently altered in chronic renal failure. Am J Physiol 280:F636-F645.
19. Miyazaki H, Sekine T, and Endou H (2004) The multispecific organic anion transporter family: properties and pharmacological significance. Trends Pharmacol Sci 25:654-662.
20. Mizuno S, Yue BF, Okamoto M, Horikawa Y, and Kurosawa T (1997) Diffuse glomerulosclerosis without tubular injury does not directly manifest renal dysfunction in nephrotic mice (ICGN strain). Exp Nephrol 5:498-507.
21. Motohashi H, Sakurai Y, Saito H, Masuda S, Urakami Y, Goto M, Fukatsu A, Ogawa O, and Inui K (2002) Gene expression levels and immunolocalization of organic ion transporters in the human kidney. J Am Soc Nephrol 13:866-874.
22. Nakajima N, Sekine T, Cha SH, Tojo A, Hosoyamada M, Kanai Y, Yan K, Awa S, and Endou H (2000) Developmental changes in multispecific organic anion transporter 1 expression in the rat kidney. Kidney Int 57:1608-1616.
23. Niwa T (1996) Organic acids and the uremic syndrome: protein metabolite hypothesis in the progression of chronic renal failure. Semin Nephrol 16:167-182.
24. Ohtsuki S, Asaba H, Takanaga H, Deguchi T, Hosoya K, Otagiri M, and Terasaki T (2002) Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain. J Neurochem 83:57-66.
25. Porter RD, Cathcart-Rake WF, Wan SH, Whittier FC, and Grantham JJ (1975) Secretory activity and aryl acid content of serum, urine and cerebrospinal fluid in normal and uremic man. J Lab Clin Med 85:723-731.
26. Sakai T, Maruyama T, Imamura H, Shimada H, and Otagiri M (1996) Mechanism of stereoselective serum binding of ketoprofen after hemodialysis. J Pharmacol Exp Ther 278:786-792.
27. Sakai T, Takadate A, and Otagiri M (1995) Characterization of binding site of uremic toxins on human serum albumin. Biol Pharm Bull 18:1755-1761.
28. Sakurai Y, Motohashi H, Ueo H, Masuda S, Saito H, Okuda M, Mori N, Matsuura M, Doi T, Fukatsu A, et al. (2004) Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseases. Pharm Res 21:61-67.
29. Satoh M, Hayashi H, Watanabe M, Ueda K, Yamato H, Yoshioka T, and Motojima M (2003) Uremic toxins overload accelerates renal damage in a rat model of chronic renal failure. Nephron Exp Nephrol 95:e111-e118.
30. Schoots AC, De Vries PM, Thiemann R, Hazejager WA, Visser SL, and Oe PL (1989) Biochemical and neurophysiological parameters in hemodialyzed patients with chronic renal failure. Clin Chim Acta 185:91-107.
31. Spustova V, Cernay P, and Golier I (1989) Inhibition of glucose utilization in uremia by hippurate: liquid chromatographic isolation and mass spectrometric and nuclear magnetic resonance spectroscopic identification. J Chromatogr 490:186-192.
32. Spustova V, Dzurik R, and Gerykova M (1987) Hippurate participation in the inhibition of glucose utilization in renal failure. Czech Med 10:79-89.
33. Sweet DH, Miller DS, Pritchard JB, Fujiwara Y, Beier DR, and Nigam SK (2002) Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8)) knockout mice. J Biol Chem 277:26934-26943.
34. Tsutsumi Y, Deguchi T, Takano M, Takadate A, Lindup WE, and Otagiri M (2002) Renal disposition of a furan dicarboxylic acid and other uremic toxins in the rat. J Pharmacol Exp Ther 303:880-887.
35. Tsutsumi Y, Maruyama T, Takadate A, Goto M, Matsunaga H, and Otagiri M (1999) Interaction between two dicarboxylate endogenous substances, bilirubin and an uremic toxin, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, on human serum albumin. Pharm Res 16:916-923.
36. Urakami Y, Kimura N, Okuda M, and Inui K (2004) Creatinine transport by basolateral organic cation transporter hOCT2 in the human kidney. Pharm Res 21: 976-981.
37. Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, et al. (2003) Review on uremic toxins: classification, concentration and interindividual variability. Kidney Int 63:1934-1943.
38. van Olden RW, van Acker BA, Koomen GC, Krediet RT, and Arisz L (1998) Contribution of tubular anion and cation secretion to residual renal function in chronic dialysis patients. Clin Nephrol 49:167-172.
39. Yamaoka K, Tanigawara Y, Nakagawa T, and Uno T (1981) A pharmacokinetic analysis program (multi) for microcomputer. J Pharmacobio-Dyn 4:879-885.
40. Youngblood GL and Sweet DH (2004) Identification and functional assessment of the novel murine organic anion transporter Oat5 (Slc22a19) expressed in kidney. Am J Physiol 287:F236-F244.